Related Experiment Video
Updated: Apr 29, 2026
06:07
Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
2.5K
Development of a DUSP9 methylation screening assay.
Stefan Jenner1, Klaus Herrmann Wiedorn, Dieter Techel
1Division of Molecular Pathology, Department of Pathology, Katharinen Hospital Stuttgart, Stuttgart, Germany, S.Jenner@Klinikum-Stuttgart.de.
Pathology Oncology Research : POR
|May 20, 2014
Summary
Dual-specificity phosphatase 9 (DUSP9) promoter methylation is significantly increased in most colorectal cancer (CRC) tumors. This aberrant methylation may serve as a potential biomarker for the CpG island methylator phenotype (CIMP) in CRC.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Aberrant promoter methylation of tumor suppressor genes is a hallmark of the CpG island methylator phenotype (CIMP) in colorectal cancer (CRC).
- Identifying novel biomarkers for CIMP is crucial for understanding CRC subtypes and patient prognosis.
Purpose of the Study:
- To develop and apply a methylation screening assay for DUSP9 (dual-specificity phosphatase 9).
- To investigate the methylation status of DUSP9 in colorectal cancer (CRC) tissues and its association with CIMP.
Main Methods:
- Quantitative pyrosequencing was employed to determine DUSP9 promoter methylation in 79 CRC FFPE samples and 22 tumor-free controls.
- Analysis focused on 83 CpG motifs within the DUSP9 promoter CpG island.
Main Results:
- Strongly methylated DUSP9 was observed in 82% of CRC tumors compared to their tumor-free counterparts.
- Weakly methylated DUSP9 showed no significant difference in 46% of cases, with alterations in 27%.
- CIMP features were present in 82% of strongly methylated DUSP9 cases, but absent in weakly methylated cases.
Conclusions:
- DUSP9 exhibits significant aberrant promoter methylation in a majority of colorectal cancer (CRC) cases.
- DUSP9 methylation status correlates with the presence of CIMP features, suggesting its potential utility as a CIMP biomarker in CRC.
